Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: Single-center experience

被引:76
|
作者
Morgera, S
Scholle, C
Voss, G
Haase, M
Vargas-Hein, O
Krausch, D
Melzer, C
Rosseau, S
Zuckermann-Becker, H
Neumayer, HH
机构
[1] Humboldt Univ, Charite, Dept Nephrol, D-1086 Berlin, Germany
[2] Humboldt Univ, Charite, Dept Anesthesiol, D-1086 Berlin, Germany
[3] Humboldt Univ, Charite, Dept Cardiol, D-1086 Berlin, Germany
[4] Humboldt Univ, Charite, Dept Infect Dis, D-1086 Berlin, Germany
[5] Humboldt Univ, Charite, Dept Surg, D-1086 Berlin, Germany
来源
NEPHRON CLINICAL PRACTICE | 2004年 / 97卷 / 04期
关键词
citrate anticoagulation; continuous renal replacement therapy; metabolic complications;
D O I
10.1159/000079171
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Regional anticoagulation with trisodium citrate is an effective form of anticoagulation for continuous renal replacement therapy (CRRT) in patients at a high risk of bleeding. In a prospective, observational study we compared an established regional citrate anticoagulation protocol [Mehta R et al: Kidney Int 1990; 38: 976-981] versus a standard heparin anticoagulation protocol focusing on acid-base and electrolyte derangements as well as on cost effectiveness. Methods and Results: 209 patients were included in the study. In 37 patients, citrate was used as the sole anticoagulant, 87 patients received low-dose heparin plus citrate, and 85 patients received only heparin as anticoagulant. A customized dialysate solution was used for citrate-anticoagulated CRRT (no buffer, no calcium, reduced sodium concentration). Filter life was significantly higher during citrate anticoagulation compared to heparin anticoagulation (80.2 +/- 60 vs. 30.2 +/- 32 h; p < 0.001). No difference was found between citrate and citrate-heparin anticoagulation (p = 0.310). Metabolic alkalosis was observed in more than 50% of patients on citrate anticoagulation. Alkalosis developed within the first 72 h after initiating treatment and could be reversed in almost all cases by increasing the dialysate flow rate. Hypercalcemia was observed in 13 patients on citrate anticoagulation. Patients with impaired liver function were particularly at risk. Systemic hypocalcemia, hypernatremia, and anion gap acidosis were not observed. Citrate anticoagulation was well tolerated hemodynamically. A longer filter life during citrate anticoagulation translated into a significant cost reduction compared to standard heparin anticoagulation (p < 0.01). Conclusion: Regional anticoagulation with trisodium citrate in combination with a customized calcium-free dialysate is a safe and effective alternative to a heparin-based anticoagulation regimen. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:C131 / C136
页数:6
相关论文
共 50 条
  • [21] Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions
    Cointault, O
    Kamar, N
    Bories, P
    Lavayssiere, L
    Angles, O
    Rostaing, L
    Genestal, M
    Durand, D
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (01) : 171 - 178
  • [22] REGIONAL ANTICOAGULATION DURING HEMODIALYSIS USING CITRATE
    MORITA, Y
    HALL, DS
    JOHNSON, RW
    DORN, RE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1961, 242 (01): : 32 - &
  • [23] A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF)
    Hofmann, RM
    Maloney, C
    Ward, DM
    Becker, BN
    RENAL FAILURE, 2002, 24 (03) : 325 - 335
  • [24] Spectrum of Intradialytic Complications during Hemodialysis and Its Management: A Single-Center Experience
    Prabhakar
    Singh, Rana Gopal
    Singh, Shivendra
    Rathore, Surendra Singh
    Choudhary, Tauhidul Alam
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2015, 26 (01) : 168 - 172
  • [25] Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury
    Silva, Veronica Torres Costa e
    Caires, Renato Antunes
    Bezerra, Juliana Silva
    Costalonga, Elerson C.
    Leandro Oliveira, Ana Paula
    Coelho, Fernanda Oliveira
    Fukushima, Julia T.
    Soares, Cilene Muniz
    Oikawa, Luciane
    Hajjar, Ludhmila Abrahao
    Burdmann, Emmanuel A.
    JOURNAL OF CRITICAL CARE, 2018, 47 : 302 - 309
  • [26] Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
    Torsten Slowinski
    Stanislao Morgera
    Michael Joannidis
    Thomas Henneberg
    Reto Stocker
    Elin Helset
    Kirsti Andersson
    Markus Wehner
    Justyna Kozik-Jaromin
    Sarah Brett
    Julia Hasslacher
    John F. Stover
    Harm Peters
    Hans-H. Neumayer
    Detlef Kindgen-Milles
    Critical Care, 19
  • [27] Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
    Slowinski, Torsten
    Morgera, Stanislao
    Joannidis, Michael
    Henneberg, Thomas
    Stocker, Reto
    Helset, Elin
    Andersson, Kirsti
    Wehner, Markus
    Kozik-Jaromin, Justyna
    Brett, Sarah
    Hasslacher, Julia
    Stover, John F.
    Peters, Harm
    Neumayer, Hans-H.
    Kindgen-Milles, Detlef
    CRITICAL CARE, 2015, 19
  • [28] The Use of Regional Citrate Anticoagulation Continuous Venovenous Hemofiltration in Extracorporeal Membrane Oxygenation
    Shum, Hoi-Ping
    Kwan, Arthur Ming-Chit
    Chan, King-Chung
    Yan, Wing-Wa
    ASAIO JOURNAL, 2014, 60 (04) : 413 - 418
  • [29] Continuous Venovenous Hemofiltration with or without predilution regional citrate anticoagulation: A prospective study
    Nurmohamed, S. Azam
    Vervloet, Marc G.
    Girbes, Armand R. J.
    Ter Wee, Pieter M.
    Groeneveld, A. B. Johan
    BLOOD PURIFICATION, 2007, 25 (04) : 316 - 323
  • [30] The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury
    Durao, Marcelino S.
    Monte, Julio C. M.
    Batista, Marcelo C.
    Oliveira, Moacir
    Iizuka, Ilson J.
    Santos, Bento F.
    Pereira, Virgilio G.
    Cendoroglo, Miguel
    Santos, Oscar F. P.
    CRITICAL CARE MEDICINE, 2008, 36 (11) : 3024 - 3029